for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Proteome Sciences plc

PRM.L

現在値

3.85GBp

変化

0.59(+18.04%)

出来高

13,100

本日のレンジ

3.44

 - 

3.44

52週レンジ

2.55

 - 

7.00

∙ 約20分前の相場を表示しています。

価格

前日終値
3.26
始値
3.44
出来高
13,100
3か月平均出来高
5.54
高値
3.44
安値
3.44
52週高値
7.00
52週安値
2.55
発行済株式数
295.18
時価総額
9.62
予想PER
--
配当利回り
--

次のエベント

Proteome Sciences PLC Annual Shareholders Meeting

適時開示

その他

Proteome Sciences Appoints Mariola Söhngen As CEO

Proteome Sciences PLC Posts FY Profit After Tax

Proteome Sciences FY Rev Up 24%

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Proteome Sciences plcとは

Proteome Sciences plc is a protein biomarker company specializing in proteomics and peptidomics services and applications, and mass spectrometry (MS) protein analysis. The Company is engaged in biomarker research and development in applied proteomics and workflows using its techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. It operates through the EU (the United Kingdom and Germany) and the United States geographic regions. Through the United Kingdom segment, it provides protein separation and MS capabilities for identification and analysis of post-translational modification of proteins in protein phosphorylation, image analysis and bioinformatics. Through the Germany segment, it provides protein profiling technologies, such as Tandem Mass Tags (TMT), which offers quantitation of proteins for the discovery of biomarkers. It has research agreements with various institutions in the United States.

業種

Biotechnology & Drugs

連絡先

Hamilton House, Mabledon Place

WC1H 9BB

United Kingdom

+44.20.70432116

https://www.proteomics.com/

エグゼクティブリーダーシップ

Christopher D. J. Pearce

Executive Chairman of the Board

Mariola Sohngen

Chief Executive Officer, Director

Geoffrey John Ellis

Finance Director, Company Secretary, Director

Malcolm Ward

Chief Technical Officer - London Research Facility

Ian H. Pike

Chief Scientific Officer, Executive Director

統計

株価売上高倍率(過去12カ月)
155.24
株価売上高倍率(過去12カ月)
2.00
株価純資産倍率(四半期)
--
株価キャッシュフロー倍率
45.61
総負債/総資本(四半期)
--
長期負債/資本(四半期)
--
投資利益率(過去12カ月)
--
自己資本利益率(過去12カ月)
0.76

最新ニュース

最新ニュース

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up